Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Andrew Blauvelt*, Kristian Reich, Tsen Fang Tsai, Stephen Tyring, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Ronald Vender, Sophie Hugot, Ruquan You, Marina Milutinovic, Diamant Thaçi
*Korrespondierende/r Autor/-in für diese Arbeit
- Oregon Medical Research Center
- Dermatologikum Hamburg and SCIderm Research Institute
- National Taiwan University Hospital
- Baylor College of Medicine
- Hospital 12 de Octubre
- University of Tartu
- Emek Medical Center
- Johann Wolfgang Goethe-Universität
- Hamilton Health Sciences
- Novartis Pharma AG
- Novartis Beijing Novartis Pharma Co Ltd
281
Link öffnet neuen Tab
Zitate (Scopus)